Innate Pharma S.A. (IPHA)

NASDAQ: IPHA · Real-Time Price · USD

2.24

0.03 (1.13%)

At close: May 02, 2025, 3:58 PM

2.26

0.89%

After-hours: May 02, 2025, 04:00 PM EDT

Innate Pharma S.A. Income Statement

Financials in EUR. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	51.9M	49.64M	12.11M	69.77M	68.97M	79.89M	32.63M	56.16M
Cost of Revenue	56.02M	51.66M	47M	49.71M	45.16M	69.56M	67M	48.63M
Gross Profit	-4.12M	-2.02M	-34.89M	20.07M	23.82M	10.34M	-34.37M	7.53M
Operating Income	-12.67M	-11.65M	-47.83M	1.08M	-27.05M	5.15M	-39.98M	7.57M
Interest Income	3.18M	4.78M	6.34M	n/a	1.62M	1.58M	1.25M	n/a
Pretax Income	-7.57M	-57.97M	-45.48M	-829K	-20.76M	2.72M	-48.02M	12.94M
Net Income	-7.57M	-99.1M	-59.14M	-63.98M	-20.96M	3.05M	-48.38M	12.64M
Selling & General & Admin	11.75M	22.44M	25.52M	18.99M	49.58M	19.25M	16.18M	9.33M
Research & Development	56.02M	51.66M	47M	49.71M	1.6M	69.56M	67M	48.63M
Other Expenses	-3.2M	-8.04M	-12.59M	-49.71M	-309K	-14.06M	-10.57M	-9.37M
Operating Expenses	64.57M	66.06M	59.94M	18.99M	50.87M	74.75M	72.61M	48.59M
Interest Expense	640K	5.32M	4M	n/a	204K	102K	113K	124K
Selling & Marketing Expenses	n/a	7.96M	9.53M	408K	8.85M	1.11M	527K	450K
Cost & Expenses	64.57M	66.06M	59.94M	68.69M	96.03M	74.75M	72.61M	48.59M
Income Tax Expense	n/a	41.13M	13.66M	n/a	206K	-333K	368K	301K
Shares Outstanding (Basic)	84.11M	79.64M	79.54M	6.09B	66.91M	58.78M	54.35M	53.87M
Shares Outstanding (Diluted)	84.11M	79.64M	79.54M	78.93M	66.91M	58.78M	54.35M	53.87M
EPS (Basic)	-0.09	-1.24	-0.74	-0.01	-0.31	0.05	-0.89	0.23
EPS (Diluted)	-0.09	-1.24	-0.74	-0.01	-0.31	0.05	-0.89	0.23
EBITDA	-1.84M	-61.3M	-43.23M	13.3M	-20.86M	-3.3M	-35.65M	10.83M
EBIT	-6.93M	-57.68M	-45.17M	1.08M	1.57M	5.15M	-39.98M	13.06M
Depreciation & Amortization	5.09M	4.42M	4.57M	12.23M	16.53M	7.4M	4.4M	3.26M